(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Basic information
- Product Name:
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
- Synonyms:
-
- (3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride (1:2)
- 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride(1:2),(3S,4S)-
- Tofacitinib-2
- Tofacitinib impurity 1/(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
- Tofacitinib Impurity 18 DiHCl
- Azilsartan medoxomil impurity350
- (3S,4S)-1-benzyl-N,4-dimethyl-3-piperidinamine dihydrochloride
- Tofacitinib Impurity 108 DiHCl
- CAS:
- 1354486-07-9
- MF:
- C14H22N2
- MW:
- 218.33788
- EINECS:
- 807-114-7
- Mol File:
- 1354486-07-9.mol
More
Less
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Chemical Properties
- storage temp.
- Inert atmosphere,Room Temperature
- Appearance
- White to off-white Solid
- InChI
- InChI=1/C14H22N2/c1-12-8-9-16(11-14(12)15-2)10-13-6-4-3-5-7-13/h3-7,12,14-15H,8-11H2,1-2H3/t12-,14+/s3
- InChIKey
- NVKDDQBZODSEIN-DCHPQEBHNA-N
- SMILES
- N1(CC2=CC=CC=C2)CC[C@H](C)[C@H](NC)C1 |&1:10,12,r|
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMineSupplier
Lanzhou HuaHao Pharmaceutical Co., Ltd. Gold
- Tel
- 18189674620
- 761137152@qq.com
ChemFuture PharmaTech (Jiangsu) Ltd
- Tel
- 5108538618
- suger.wang@chemfuture.com
Adamas Reagent, Ltd.
- Tel
- 400-6009262 16621234537
- chenyj@titansci.com
Shanghai Boc Chemical Co.,Ltd
- Tel
- 021-34975603-808 18721111801
- sales@bocpharma.com
Beijing Lunarsun Pharmaceutical Co.,LTD.
- Tel
- 86-10-64911848-8020.8010
- sales@lunarsun.com.cn
More
Less
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine(1354486-07-9)Related Product Information
- (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine
- 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE
- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
- 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol
- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE
- 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine
- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
- 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
- Tofacitinib
- Tofacitinib Impurity 2
- N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine